» Articles » PMID: 28751877

Autoimmune Abnormalities of Postpartum Thyroid Diseases

Overview
Specialty Endocrinology
Date 2017 Jul 29
PMID 28751877
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

The year following parturition is a critical time for the appearance or exacerbation of autoimmune diseases, including autoimmune thyroid disease. The vast majority of postpartum thyroid disease consists of postpartum thyroiditis (PPT) and the minority by Graves' disease and non-autoimmune thyroiditis. PPT has a worldwide prevalence ranging from 1 to 22% and averaging 5% based on a review published in 2012. Several factors confer risk for the development of PPT. Typically, the clinical course of PPT is characterized by three phases: thyrotoxic, hypothyroid, and euthyroid phase. Approximately half of PPT women will have permanent hypothyroidism. The best humoral marker for predictivity, already during the first trimester of gestation, is considered positivity for thyroperoxidase autoantibodies (TPOAb), though only one-third to half of such TPOAb-positive pregnant women will develop PPT. Nutraceuticals (such as selenium) or omega-3-fatty acid supplements seem to have a role in prevention of PPT. In a recent study on pregnant women with stable dietary habits, we found that the fish consumers had lower rates of positivity (and lower serum levels) of both TPOAb and thyroglobulin Ab compared to meat eaters. Finally, we remind the reader of other diseases that can be observed in the postpartum period, either autoimmune or non-autoimmune, thyroid or non-thyroid.

Citing Articles

Omega-3 fatty acid supplements and recurrent miscarriage: A perspective on potential mechanisms and clinical evidence.

Mu F, Huo H, Wang M, Wang F Food Sci Nutr. 2023; 11(8):4460-4471.

PMID: 37576058 PMC: 10420786. DOI: 10.1002/fsn3.3464.


The C55A Single Nucleotide Polymorphism in Gene, a New Possible Biomarker in Thyroid Autoimmune Pathology Such as Hashimoto's Thyroiditis.

Chiorean A, Vica M, Balici S, Nicula G, Racataianu N, Bordea M Diagnostics (Basel). 2023; 13(15).

PMID: 37568880 PMC: 10417055. DOI: 10.3390/diagnostics13152517.


Clinical efficacy of selenium supplementation in patients with Hashimoto thyroiditis: A systematic review and meta-analysis.

Kong X, Qiu G, Yang Z, Tan Z, Quan X Medicine (Baltimore). 2023; 102(20):e33791.

PMID: 37335715 PMC: 10194801. DOI: 10.1097/MD.0000000000033791.


Selenium Deficiency Due to Diet, Pregnancy, Severe Illness, or COVID-19-A Preventable Trigger for Autoimmune Disease.

Schomburg L Int J Mol Sci. 2021; 22(16).

PMID: 34445238 PMC: 8395178. DOI: 10.3390/ijms22168532.


Total T4 rise in pregnancy: a relook?.

Pramanik S, Mukhopadhyay P, Ghosh S Thyroid Res. 2020; 13:14.

PMID: 32760451 PMC: 7393699. DOI: 10.1186/s13044-020-00088-5.


References
1.
Elefsiniotis I, Vezali E, Pantazis K, Saroglou G . Post-partum thyroiditis in women with chronic viral hepatitis. J Clin Virol. 2008; 41(4):318-9. DOI: 10.1016/j.jcv.2007.12.010. View

2.
Drucker D, Shumak S, Angel A . Schmidt's syndrome presenting with intrauterine growth retardation and postpartum addisonian crisis. Am J Obstet Gynecol. 1984; 149(2):229-30. DOI: 10.1016/0002-9378(84)90206-0. View

3.
Amino N, Mori H, Iwatani Y, TANIZAWA O, Kawashima M, Tsuge I . High prevalence of transient post-partum thyrotoxicosis and hypothyroidism. N Engl J Med. 1982; 306(14):849-52. DOI: 10.1056/NEJM198204083061405. View

4.
Misaki T, Miyamoto S, Kasagi K, Mori T, Konishi J . Serial occurrence of two types of postpartum thyroid disorders. Usefulness of Tc-99m pertechnetate uptake. Clin Nucl Med. 1996; 21(6):460-2. DOI: 10.1097/00003072-199606000-00005. View

5.
Walfish P, Meyerson J, Provias J, Vargas M, Papsin F . Prevalence and characteristics of post-partum thyroid dysfunction: results of a survey from Toronto, Canada. J Endocrinol Invest. 1992; 15(4):265-72. DOI: 10.1007/BF03348726. View